UnitedHealth Group Q4 Adjusted EPS $6.16 Beats $5.98 Estimate, Sales $94.43B Beat $92.14B Estimate
Portfolio Pulse from Benzinga Newsdesk
UnitedHealth Group (UNH) exceeded Q4 earnings and sales estimates, with an adjusted EPS of $6.16, surpassing the $5.98 forecast, and sales of $94.43B, beating the $92.14B estimate. This represents a 15.36% increase in EPS and a 14.06% increase in sales compared to the same period last year.
January 12, 2024 | 10:56 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UnitedHealth Group reported a strong Q4 with EPS of $6.16 and sales of $94.43B, both surpassing analyst expectations and showing significant year-over-year growth.
UnitedHealth's earnings beat typically indicates positive investor sentiment and could lead to a short-term uptick in stock price. The substantial year-over-year growth in both EPS and sales further strengthens the case for a positive market reaction.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100